Pacific Edge secures vital Medicare draft coverage
Pacific Edge (ASX:PEB) secured a regulatory win as Novitas publishes draft Medicare coverage for Cxbladder Triage tests.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Pacific Edge (ASX:PEB) secured a regulatory win as Novitas publishes draft Medicare coverage for Cxbladder Triage tests.
Argenica Therapeutics (ASX:AGN) has formed a Clinical Advisory Committee to lead its Phase 2b trial for the neuroprotective candidate, ARG-007.
Nexalis Therapeutics (ASX:NX1) announced a clinical milestone following the final dosing of its Phase 1 study for IRX-616a.
Neurizon Therapeutics (ASX:NUZ) secures ethics approval for a Phase 1 study of its NUZ-001 oral liquid formulation.
Firebrick Pharma (ASX:FRE) has achieved a regulatory milestone in North America with the Canadian Intellectual Property Office.
Nexsen (ASX:NXN) has achieved a milestone in its international expansion, announcing a binding term sheet with GHK Hospital.
Cancer diagnostics firm Pacific Edge (ASX:PEB) has capitalised on investor appetite, announcing an upsized NZ$25.4 million equity placement.
Healius (ASX:HLS) narrowed its EBITDA guidance to $259M–$264M and launched a strategic asset review for FY26.
Biome Australia (ASX:BIO) executed a two-year extension to its exclusive supply agreement with Probiotical.
Bioxyne (ASX:BXN) announced a major $50 million exclusive supply agreement with German pharmaceutical giant ADREXpharma.
EMVision Medical Devices (ASX:EMV) announced an expansion of its pivotal FDA De Novo trial.
BCAL Diagnostics (ASX:BDX), an Australian healthcare innovator specialising in early-stage cancer detection, appointed Anne-Louise Arnett as its CEO.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade